$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, v.17 no.10, 2015년, pp.825 - 829  

Song, S. ,  Kim, K. ,  Chie, E. K. ,  Kim, S. ,  Park, H. J. ,  Yi, N. J. ,  Suh, K.-S. ,  Ha, S. W.

Abstract AI-Helper 아이콘AI-Helper

As for intrahepatic cholangiocarcinoma, the most frequent site of failure after curative intent resection is the liver. We identified the risk factors for locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma....

참고문헌 (22)

  1. Surg Clin North Am GA Poultsides 90 817 2010 10.1016/j.suc.2010.04.011 Poultsides GA, Zhu AX, Choti MA, Pawlik TM. Intrahepatic cholangiocarcinoma. Surg Clin North Am. 2010;90:817-37. 

  2. HPB (Oxford) SA Khan 10 77 2008 10.1080/13651820801992641 Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008;10:77-82. 

  3. Gastroenterology S Rizvi 145 1215 2013 10.1053/j.gastro.2013.10.013 Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145:1215-29. 

  4. Surgery K Shirabe 131 S159 2002 10.1067/msy.2002.119498 Shirabe K, Shimada M, Harimoto N, Sugimachi K, Yamashita Y, Tsujita E, et al. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery. 2002;131:S159-64. 

  5. Ann Surg Oncol JC Tan 15 600 2008 10.1245/s10434-007-9627-x Tan JC, Coburn NG, Baxter NN, Kiss A, Law CH. Surgical management of intrahepatic cholangiocarcinoma-a population-based study. Ann Surg Oncol. 2008;15:600-8. 

  6. J Hepatobiliary Pancreat Surg T Uenishi 15 417 2008 10.1007/s00534-007-1315-5 Uenishi T, Kubo S, Yamazaki O, Yamada T, Sasaki Y, Nagano H, et al. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg. 2008;15:417-22. 

  7. Ann Surg Oncol H Nathan 16 14 2009 10.1245/s10434-008-0180-z Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16:14-22. 

  8. Surgery K Shimada 145 411 2009 10.1016/j.surg.2008.11.010 Shimada K, Sano T, Nara S, Esaki M, Sakamoto Y, Kosuge T, et al. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery. 2009;145:411-6. 

  9. Ann Surg O Farges 254 824 2011 10.1097/SLA.0b013e318236c21d Farges O, Fuks D, Boleslawski E, Le Treut YP, Castaing D, Laurent A, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg. 2011;254:824-9. 

  10. Ann Surg I Endo 248 84 2008 10.1097/SLA.0b013e318176c4d3 Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248:84-96. 

  11. Int J Radiat Oncol Biol Phys F Giuliante 78 S196 2010 10.1016/j.ijrobp.2010.07.475 Giuliante F, Ardito F, Mattiucci GC, Barbaro B, de Rose AM, Ranucci G, et al. Patterns of recurrence following liver resection for intrahepatic cholangiocarcinoma (IHC) and recurrence location risk score (RLRS) to identify patients suitable for loco-regional treatment and volumes of interest. Int J Radiat Oncol Biol Phys. 2010;78:S196. 

  12. SB Edge 2010 American Joint Committee on Cancer. AJCC cancer staging manual 7 Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. 

  13. J Am Coll Surg H Lang 208 218 2009 10.1016/j.jamcollsurg.2008.10.017 Lang H, Sotiropoulos GC, Sgourakis G, Schmitz KJ, Paul A, Hilgard P, et al. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg. 2009;208:218-28. 

  14. Ann Surg G Ercolani 252 107 2010 10.1097/SLA.0b013e3181e462e6 Ercolani G, Vetrone G, Grazi GL, Aramaki O, Cescon M, Ravaioli M, et al. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg. 2010;252:107-14. 

  15. J Am Coll Surg SM Weber 193 384 2001 10.1016/S1072-7515(01)01016-X Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg. 2001;193:384-91. 

  16. Surgery O Hyder 153 811 2013 10.1016/j.surg.2012.12.005 Hyder O, Hatzaras I, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery. 2013;153:811-8. 

  17. Am J Surg A Saiura 201 203 2011 10.1016/j.amjsurg.2008.12.035 Saiura A, Yamamoto J, Kokudo N, Koga R, Seki M, Hiki N, et al. Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections. Am J Surg. 2011;201:203-8. 

  18. J Gastrointest Surg A Saxena 14 1128 2010 10.1007/s11605-010-1203-1 Saxena A, Chua TC, Sarkar A, Chu F, Morris DL. Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit. J Gastrointest Surg. 2010;14:1128-38. 

  19. Ann Surg Oncol K Shirabe 17 1816 2010 10.1245/s10434-010-0929-z Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S, et al. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Ann Surg Oncol. 2010;17:1816-22. 

  20. Int J Radiat Oncol Biol Phys ET Shinohara 72 1495 2008 10.1016/j.ijrobp.2008.03.018 Shinohara ET, Mitra N, Guo M, Metz JM. Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2008;72:1495-501. 

  21. J Clin Oncol E Ben-Josef 23 8739 2005 10.1200/JCO.2005.01.5354 Ben-Josef E, Normolle D, Ensminger WD, Walker S, Tatro D, Ten Haken RK, et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2005;23:8739-47. 

  22. Int J Radiat Oncol Biol Phys JH Choi 74 67 2009 10.1016/j.ijrobp.2008.06.1941 Choi JH, Kim K, Chie EK, Jang JY, Kim SW, Oh DY, et al. Does adjuvant radiotherapy suppress liver regeneration after partial hepatectomy? Int J Radiat Oncol Biol Phys. 2009;74:67-72. 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로